Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.900
-0.090 (-2.26%)
Feb 20, 2026, 4:00 PM EST - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $293.12 million as of February 20, 2026. Its market cap has increased by 154.00% in one year.
Market Cap
293.12M
Enterprise Value
329.88M
1-Year Change
154.00%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $293.12M, a decrease of -78.19%. That is a compound annual growth rate of -13.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 282.10M | -19.42% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 320.06M |
| Fennec Pharmaceuticals | 306.70M |
| ALX Oncology Holdings | 303.72M |
| Aldeyra Therapeutics | 302.02M |
| XOMA Royalty | 301.53M |
| Cabaletta Bio | 301.31M |
| Relmada Therapeutics | 299.20M |
| Armata Pharmaceuticals | 294.53M |